Carregant...
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Neutralizing antibodies could potentially be used as antivirals against the coronavirus disease 2019 (COVID-19) pandemic. Here, we report isolation of four human-origin monoclonal antibodies from a convalescent patient, all of which display neutralization abilities. The antibodies B38 and H4 block b...
Guardat en:
| Publicat a: | Science |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Association for the Advancement of Science
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223722/ https://ncbi.nlm.nih.gov/pubmed/32404477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.abc2241 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|